Werewolf Therapeutics, Inc.

HOWL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$16-$18-$18-$20
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$2
Change in WC$0-$0-$0$0
Other Non-Cash$1$1-$3$3
Operating Cash Flow-$15-$15-$19-$14
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0$0$3
Financing Cash Flow$3$0$0$3
Forex Effect$0$0$0$0
Net Chg. in Cash-$12-$15-$19-$12
Supplemental Information
Beg. Cash$78$93$112$124
End Cash$67$78$93$112
Free Cash Flow-$15-$15-$19-$14
Werewolf Therapeutics, Inc. (HOWL) Financial Statements & Key Stats | AlphaPilot